Want to join the conversation?
Provider of IT solutions and services $CSC said that Eisai Inc. has signed a three-year contract extension for $CSC's Total Regulatory Solutions (TRS) as-a-Service. This agreement extends the ongoing life sciences software and cloud-hosting services the company provides to Eisai's U.S. pharmaceutical subsidiary until Dec. 2019.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.